Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MXCT
MAXCYTE, INC.
NASDAQ
$1.28
▲ UP 1.59% (0.02)

KEY STATISTICS

Market Cap$137.12 M
52w High$1.86
52w Low$0.64
Dividend Yield—
Frequency—
P/E-4.27
Volume333.49K
Shares Out.107.12M

COMPANY

LEADERSHIP

Maher Masoud
CHIEF EXECUTIVE
Maher Masoud

COMPENSATION 2026

Salary$590,000
Stock Awards$1,724,000
Incentive Plan Pay$389,400
All Other Comp.$10,604
Total$3,611,298

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 29, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
91

PRICE TARGET

Target High$6.00
Target Low$6.00
Target Median$6.00
Target Consensus$6.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$7.02M
NOV
11
WED

PRICE

$1.28 ▲ UP 1.59% (+$0.02)
$1.26$1.27$1.299:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM1.28

About MaxCyte, Inc.

https://www.maxcyte.com ↗

MaxCyte, Inc. is a global life sciences company developing next-generation cell therapies with products like electroporation instruments and disposables for small to large-scale cell engineering and therapeutic applications.

INDUSTRY

Biotechnology

A PRODUCT MAXCYTE, INC. IS KNOWN FOR

MaxCyte ExPERT Platform
MaxCyte ExPERT Platform

The ExPERT platform, featuring models like ATx, GTx, STx, and VLx, uses MaxCyte's proprietary Flow Electroporation® technology to enable efficient cell engineering for developing and manufacturing cell-based therapies.

COMPETITORS

COMPETITOR
BIO COMPARE
HBIO COMPARE
INO COMPARE
TKNO COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$3.95M $4.15M ▲$3.64M ▼$4.1M ▲
License$2.23M $2.54M ▲$5.53M ▲$2.59M ▼

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$3.84M $3.9M ▲$6.62M ▲$4.63M ▼
NonUS$2.99M $3.4M ▲$3.04M ▼$2.64M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 2.7M

INSTITUTIONAL OWNERSHIP

SHARES OWNED
67.45%
HOLDERS
170
TOP 12 OF 170 · RANKED BY POSITION SIZE
Blackrock, Inc.
10.0M sh · $15.77M
Cadian Capital Management, LP
8.2M sh · $13M
Capricorn Fund Managers Ltd
8.2M sh · $5.76M
Mirabella Financial Services Llp
8.2M sh · $12.96M
Blackrock Inc.
8.1M sh · $31.92M
Morgan Stanley
6.7M sh · $10.58M
Vanguard Group Inc
5.6M sh · $8.83M
Vitruvian Partners Llp
5.0M sh · $3.54M
Mudita Advisors Llp
3.4M sh · $2.37M
River & Mercantile Asset Management Llp
3.3M sh · $13.49M
Bnp Paribas Asset Management Holding S.A.
2.8M sh · $1.95M
Axa Investment Managers S.A.
2.8M sh · $4.38M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR
DOUGLAS RICHARD
Purchase · 30.4K shares
2026-06-17
★
DIRECTOR
Erck Stanley C
Purchase · 49.6K shares
2026-06-17
★
DIRECTOR
Collins Cynthia
Purchase · 30.4K shares
2026-06-17
★
DIRECTOR
Collins Cynthia
Purchase · 49.6K shares
2026-06-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Craig-Hallum BUY

SECTORS PEERS

PEERPRICE
AVR$9.04COMPARE
PRE$25.44COMPARE
TLSI$5.00COMPARE
PROF$6.89COMPARE
LNSR$8.58COMPARE
OWLT$4.98COMPARE
NNOX$0.83COMPARE